Bone Biologics BBLG
NASDAQ BBLG
$0.34 +0.01 (+2.99%)
At close: Nov 10, 2026 · 4:00 PM EST

Bone Biologics (BBLG) FCF Margin (2023 - 2024)

Updated

Bone Biologics' FCF Margin was -511141.57% in Q1 2024, down 268337.07 percentage points from -242804.50% a year earlier but up 67086.23 percentage points from the prior quarter.

Analysis

Bone Biologics (BBLG) FCF Margin (2023 - 2024) Analysis & Trends

On a trailing twelve-month basis, Bone Biologics' FCF Margin was -606461.86% through Mar 31, 2024; for FY2023, it came in at -511558.03%.

  • Quarterly FCF Margin has moved between -848755.37% (Q2 2023) and -242804.50% (Q1 2023) over five years.
  • Per Business Quant data, BBLG's FCF Margin in the three quarters before Q1 2024 was -578227.79% (Q4 2023), -476720.71% (Q3 2023) and -848755.37% (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 17.41%
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 9.41%
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 24.89%
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn 36.44%
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 13.22%
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 18.77%
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 16.89%
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 29.54%
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 12.70%
10 Bone Biologics 1.34 Mn -18.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -511,141.57%
Dec 31, 2023 -578,227.79%
Sep 30, 2023 -476,720.71%
Jun 30, 2023 -848,755.37%
Mar 31, 2023 -242,804.50%
API Access

Bone Biologics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=BBLG&period=max&api_key=YOUR_API_KEY